Commentary
In this review, Yumi Ando and Janice H. Jou (Portland, OR, USA) summarise updated guidelines and guidance recommendations for the management of adult NAFLD. Interestingly, the authors highlight key difference between US, Asian, and European recommendations; and provide key updates.
Previous Post
Hepatic fibrosis and CV risk factors: the Framingham Heart Study
Next Post
Gut microbiome and fatty liver disease